The EPA under President Donald Trump notched higher enforcement numbers across several key metrics in fiscal 2025 than it has in a decade, Jeffrey Hall, head of the agency’s enforcement division, said in an interview.
A
Progressive Treatment Solutions LLC, a cannabis product maker, convinced a federal judge to toss a consumer’s proposed class action alleging the company misclassified a disposable vape cartridge in violation of Illinois law.
A federal judge on Monday allowed two Ohioans to intervene in a lawsuit over the 2023 trail derailment in East Palestine, a move that could extend the time it takes to rule on a pending $310 million settlement between the United States and Norfolk Southern Corp.
The
A large-scale drug compounder failed to show that it has standing to challenge the FDA’s decision to exclude a certain ingredient from a list that determines what can be used to make a customized medication, a federal judge ruled.
The EPA has bought time by pausing lawsuits challenging several chemical rules it plans to rewrite, but attorneys say this doesn’t guarantee the agency’s long-term legal success.
Ipsen announced Monday it is voluntarily withdrawing its Tazverik cancer drug from all markets after emerging data showed risks may outweigh benefits due to secondary hematologic malignancies.
The EPA says more than 600 PFAS chemicals are in the marketplace in the U.S. While states are racing to regulate PFAS, while the federal government lags.
Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas: